Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Sodium/glucose cotransporter 2 (SGLT2)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Sodium/glucose cotransporter 2 (SGLT2) is primarily expressed in the kidney, and it is the main transporter for the reabsorption of approximately 90% of active renal glucose from the glomerular filtrate in the early proximal tubule of the kidney.
Filippatos et al. 2015 Ther Adv Endocrinol Metab 6(1): 29-41

…

References (Sources)

Dapagliflozin in patients with type 2 diabetes mellitus
Filippatos et al. 2015 Ther Adv Endocrinol Metab 6(1): 29-41
Review

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Sodium/glucose cotransporter 2 (SGLT2)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat

Links